Dr. Scott Eagon
Synthetic Organic Chemistry
Our group focuses on the development of small molecule pharmaceuticals targeting a variety of diseases, particularly malaria and cancer. Students are involved in all aspects of drug synthesis and pre-clinical development. Our group is also interested in developing new synthetic methods to produce compounds quickly & with minimal purification in an effort to reduce development costs. Students majoring in Chemistry, Biochemistry, or related majors are welcome to join, but two quarters of organic chemistry lab are required to join due to the complexity of the chemistry involved. Students minoring in computer science are also welcome to contribute to our in silico drug screening program. Current projects include the development of kinase-based chemotherapy agents, anti-malarials with novel modes of action targeting multi-drug resistant strains of Plasmodium falciparum, synthetic opioids with minimized addiction profiles, and in silico screening programs to discover new drug candidates for infectious diseases. Click the link to the Research Website above to learn more.